The Calmer Co International Ltd
Company Profile
Business description
The Calmer Co International Ltd is mainly engaged in the research, development, and selling of kava extracts as a consumer product. Its business objective is the primary production of kava through a network of outsourced kava farms and via its Farm located in Fiji and the production and sale of kava supplements and complementary medicines. The company has produced three types of products in the market: shots, powders, and capsules. Its reportable segments are; Fiji Kava Australia Trading Pty Ltd (Fiji Kava Australia Trading) which derives maximum revenue, South Pacific Elixirs Pty Limited (SPE Fiji), Fiji Kava Inc (USA), and Danodan Hempworks LLC (USA). Geographically, it derives key revenue from Australia and the rest from Fiji, and other regions.
Contact
96 Victoria Street
West End
BrisbaneQLD4101
AUST: +61 738441010
Sector
Consumer Defensive
Stock type
Defensive
Industry
Packaged Foods
Fiscal Year End
30 June 2025
Employees
Stocks News & Analysis
stocks
Ask the analyst: Can this big Covid loser scale its former heights?
stocks
The fight for Insignia continues
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,660.40 | 31.30 | 0.36% |
| CAC 40 | 7,927.62 | 35.01 | 0.44% |
| DAX 40 | 21,394.93 | 16.60 | -0.08% |
| Dow JONES (US) | 44,424.25 | 140.82 | -0.32% |
| FTSE 100 | 8,502.35 | 62.85 | -0.73% |
| HKSE | 20,066.19 | 365.63 | 1.86% |
| NASDAQ | 19,954.30 | 99.38 | -0.50% |
| Nikkei 225 | 39,931.98 | 26.89 | -0.07% |
| NZX 50 Index | 13,024.70 | 35.38 | -0.27% |
| S&P 500 | 6,101.24 | 17.47 | -0.29% |
| S&P/ASX 200 | 8,408.90 | 30.20 | 0.36% |
| SSE Composite Index | 3,252.63 | 22.46 | 0.70% |